Respiratory Tract Microbiota
Our Respiratory Pathogen Panels (RPP) detect common respiratory pathogens like Influenza, RSV, Covid-19 and Pneumonia, as well as many less common pathogens. From a single nasal or nasopharyngeal swab, GRI Labs can detect common and not-so-common respiratory tract microbiota (RTM).
Our test options include the following:
Covid-19 with Flu, RSV, and Pneumonia (RTM-B)
Patients presenting with respiratory symptoms may have Covid-19 or a wide variety of other respiratory ailments that may have a similar presentation. Our PCR-Based Basic Respiratory Tract Microbiota (RTM-B) panel detects the most common respiratory ailments, including the following:
-
Covid-19 Active Infection
-
Influenza A & B
-
Respiratory Syncytial Virus A & B
-
Pneumonia
Both Covid-19 and flu can have symptoms that range from none (asymptomatic) to severe. Symptoms common to both ailments include cough, fever, shortness of breath, fatigue, stuffy or runny nose, sore throat, headache, body ache, diarrhea, and vomiting. With a single swab, our RTM-B test can determine which illness is present so that the right course of treatment can be established quickly. Many state departments of health, including the Nevada Department of Health and Human Services, have recommended testing for Covid-19, flu and RSV at the same time:
Comprehensive Respiratory Pathogen Panel (RTM-C)
While most of the time our Basic RPP test will uncover the pathogen causing respiratory distress, some less common pathogens are detected only by our Comprehensive Respiratory Tract Microbiota panel (RTM-C). Our RTM-C panel detects up to 33 different bacterial and viral pathogens including Covid-19. Full details of pathogens detected are shown below.
Covid-19 Only
Our “gold-standard” PCR-based diagnostic test detects the presence of an active Covid-19 infection.
Professional Reports with a Modern Look
Gone are the days of cryptic reports that are hard for patients to understand. GRI Labs provides professional and comprehensive reports customized for each patient. Presented in an up-to-date, colorful, and easy-to-read format, our reports serve as useful tools for you to discuss and share results with your patients.
Download a sample RPP Test report.
Guidance from the Mayo Clinic on Respiratory Pathogens
The following links provide guidance from the Mayo Clinic on other respiratory pathogens that are important to test for:
Covid-19 CDC Testing Guidance
The following link provides guidance on Covid-19 testing from the CDC:
Real-Time PCR Technology
GRI Labs’ system for RPP testing takes respiratory tract infection testing to the next level. Designed for maximum throughput, flexibility, and scalability, the technology sets the new standard for what a real-time PCR instrument should be. Combining flexible throughput capabilities with a streamlined workflow, intuitive software, and a state-of-the-art industrial design, these instruments support targeted discovery through confirmation and screening, and everything in between.
Viral Pathogens Detected
Adenovirus
Coronavirus HKU1
Coronavirus NL63
Coronavirus 229E
Coronavirus OC43
Coronavirus SARS-CoV-2 (Covid-19)
Human metapneumovirus
Rhinovirus
Enterovirus
Influenza A/H1-2009
Influenza A/H3
Influenza B
Influenza A (Pan)
Parainfluenza 1
Parainfluenza 2
Parainfluenza 3
Parainfluenza 4
Respiratory Syncytial Virus A
Respiratory Syncytial Virus B
Epstein-Barr virus (EBV) *
Cytomegalovirus *
Human herpesvirus 6 (HHV-6) *
Bacterial Pathogens Detected
Bordetella (PAN)*
Bordetella pertussis
Chlamydophila pneumoniae
Mycoplasma pneumoniae
Streptococcus pneumoniae
Staphylococcus aureus
Klebsiella pneumoniae
Legionella pneumoniae
Haemophilus influenzae
*Pathogens marked with an asterisk are only available with the Comprehensive RTM-C panels. All others are available with the Basic RTM-B panel.
See Covid-19 Diagnostic Test for further details on our PCR-based Covid test.